Acquired glucose‐6‐phosphate dehydrogenase deficiency after allogeneic stem‐cell transplantation

Documenti analoghi

• Graft‐versus‐host disease after autologous stem cell transplantation in a recipient who underwent allogeneic stem cell transplantation 20 years earlier
  di: Osamu Imataki, et al.
  Pubblicazione: (2024)
• Fludarabine, busulfan, and melphalan conditioning regimen in allogeneic hematopoietic stem cell transplantation for adult patients with myeloid malignancies: A multicenter retrospective study
  di: Jieling Jiang, et al.
  Pubblicazione: (2024)
• Association of the nutritional risk index recorded prior to allogeneic hematopoietic cell transplantation with the clinical prognosis in children
  di: Hitomi Yonesu, et al.
  Pubblicazione: (2024)
• Central nervous system posttransplant lymphoproliferative disorder following allogeneic hematopoietic stem cell transplantation successfully treated with combination therapy of acalabrutinib and immunochemotherapy: A case report and literature review
  di: Peihao Zheng, et al.
  Pubblicazione: (2024)
• Allogeneic stem cell transplant recipients surviving at least 2 years without relapse: outcome and risk factors
  di: B. Linder Grønvold, et al.
  Pubblicazione: (2024)